These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19939577)

  • 81. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?
    Teh BS; McGary JE; Dong L; Mai WY; Carpenter LS; Lu HH; Chiu JK; Woo SY; Grant WH; Butler EB
    Cancer J; 2002; 8(6):476-83. PubMed ID: 12500857
    [TBL] [Abstract][Full Text] [Related]  

  • 82. SpaceOAR© hydrogel rectal dose reduction prediction model: a decision support tool.
    Paetkau O; Gagne IM; Alexander A
    J Appl Clin Med Phys; 2020 Jun; 21(6):15-25. PubMed ID: 32250042
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Validation of rectal sparing throughout the course of proton therapy treatment in prostate cancer patients treated with SpaceOAR
    Hedrick SG; Fagundes M; Case S; Renegar J; Blakey M; Artz M; Chen H; Robison B; Schreuder N
    J Appl Clin Med Phys; 2017 Jan; 18(1):82-89. PubMed ID: 28291933
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A fully automated method for CT-on-rails-guided online adaptive planning for prostate cancer intensity modulated radiation therapy.
    Li X; Quan EM; Li Y; Pan X; Zhou Y; Wang X; Du W; Kudchadker RJ; Johnson JL; Kuban DA; Lee AK; Zhang X
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):835-41. PubMed ID: 23726001
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.
    Reddy NM; Nori D; Chang H; Lange CS; Ravi A
    Med Phys; 2010 Jul; 37(7):3791-801. PubMed ID: 20831087
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The dosimetric advantages of perirectal hydrogel spacer in men with localized prostate cancer undergoing stereotactic ablative radiotherapy (SABR).
    Sturt P; Suh YE; Khoo V
    Med Dosim; 2022 Summer; 47(2):173-176. PubMed ID: 35277316
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.
    De Meerleer GO; Vakaet LA; De Gersem WR; De Wagter C; De Naeyer B; De Neve W
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):639-48. PubMed ID: 10837946
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate Cancer.
    Boissier R; Udrescu C; Rebillard X; Terrier JE; Faix A; Chapet O; Azria D; Devonec M; Paparel P; Ruffion A
    Urology; 2017 Jan; 99():265-269. PubMed ID: 27725233
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.
    Ost P; Speleers B; De Meerleer G; De Neve W; Fonteyne V; Villeirs G; De Gersem W
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):920-6. PubMed ID: 20675077
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer.
    Wilder RB; Barme GA; Gilbert RF; Holevas RE; Kobashi LI; Reed RR; Solomon RS; Walter NL; Chittenden L; Mesa AV; Agustin J; Lizarde J; Macedo J; Ravera J; Tokita KM
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):824-30. PubMed ID: 20510195
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
    Moore KL; Brame RS; Low DA; Mutic S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The effect of anterior proton beams in the setting of a prostate-rectum spacer.
    Christodouleas JP; Tang S; Susil RC; McNutt TR; Song DY; Bekelman J; Deville C; Vapiwala N; Deweese TL; Lu HM; Both S
    Med Dosim; 2013; 38(3):315-9. PubMed ID: 23578497
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
    Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer.
    Chan LW; Xia P; Gottschalk AR; Akazawa M; Scala M; Pickett B; Hsu IC; Speight J; Roach M
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):69-77. PubMed ID: 18342454
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy.
    Boehmer D; Kuczer D; Badakhshi H; Stiefel S; Kuschke W; Wernecke KD; Budach V
    Strahlenther Onkol; 2006 May; 182(5):277-82. PubMed ID: 16673061
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis.
    Onal C; Topkan E; Efe E; Yavuz M; Sonmez S; Yavuz A
    Radiat Oncol; 2009 May; 4():14. PubMed ID: 19432953
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Feasibility of Same-Day Prostate Fiducial Markers, Perirectal Hydrogel Spacer Placement, and Computed Tomography and Magnetic Resonance Imaging Simulation for External Beam Radiation Therapy for Low-Risk and Intermediate-Risk Prostate Cancer.
    Brenneman RJ; Goddu SM; Andruska N; Roy A; Bosch WR; Fischer-Valuck B; Efstathiou JA; Gay HA; Michalski JM; Baumann BC
    Pract Radiat Oncol; 2022; 12(2):e117-e122. PubMed ID: 34695615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.